TW200634154A - Apoptosis-specific EIF-5A and polynucleotides encoding same - Google Patents

Apoptosis-specific EIF-5A and polynucleotides encoding same

Info

Publication number
TW200634154A
TW200634154A TW094142843A TW94142843A TW200634154A TW 200634154 A TW200634154 A TW 200634154A TW 094142843 A TW094142843 A TW 094142843A TW 94142843 A TW94142843 A TW 94142843A TW 200634154 A TW200634154 A TW 200634154A
Authority
TW
Taiwan
Prior art keywords
apoptosis
polynucleotides encoding
eif
encoding same
specific eif
Prior art date
Application number
TW094142843A
Other languages
English (en)
Inventor
John E Thompson
Bruce C Galton
Catherine Taylor
Charles Dinarello
Leonid Reznikov
Adrienne Boone
Marianne Hopkins
Original Assignee
Senesco Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senesco Technologies Inc filed Critical Senesco Technologies Inc
Publication of TW200634154A publication Critical patent/TW200634154A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
TW094142843A 2004-12-03 2005-12-05 Apoptosis-specific EIF-5A and polynucleotides encoding same TW200634154A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US63251404P 2004-12-03 2004-12-03
US66662605P 2005-03-31 2005-03-31
US67588405P 2005-04-29 2005-04-29
US71139705P 2005-08-26 2005-08-26

Publications (1)

Publication Number Publication Date
TW200634154A true TW200634154A (en) 2006-10-01

Family

ID=36565863

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094142843A TW200634154A (en) 2004-12-03 2005-12-05 Apoptosis-specific EIF-5A and polynucleotides encoding same

Country Status (10)

Country Link
EP (2) EP1828383A2 (zh)
JP (1) JP2008522591A (zh)
KR (1) KR20070077225A (zh)
AR (1) AR051786A1 (zh)
AU (1) AU2005311586A1 (zh)
CA (1) CA2588129A1 (zh)
IL (1) IL183585A0 (zh)
NZ (1) NZ556236A (zh)
TW (1) TW200634154A (zh)
WO (1) WO2006060823A2 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007226875A1 (en) * 2006-03-20 2007-09-27 Senesco Technologies, Inc. Use of eiF-5A1 siRNA and antisense to treat sepsis or haemorrhagic shock
US8703929B2 (en) * 2008-03-07 2014-04-22 Senesco Technologies, Inc. Compositions comprising siRNA and plasmids
WO2009144933A1 (ja) * 2008-05-27 2009-12-03 国立大学法人東京大学 アポトーシス誘導薬
AR073274A1 (es) * 2008-09-03 2010-10-28 Senesco Technologies Inc Composicion. uso de un polinucleotido de eif-5a1 truncado para inducir apoptosis en celulas cancerosas
JP5302054B2 (ja) * 2009-03-06 2013-10-02 オリンパス株式会社 Ｄｎａが断片化されたアポトーシス細胞の検出方法、細胞画像解析装置、及びプログラム
FR2962906A1 (fr) 2010-07-20 2012-01-27 Univ Nice Sophia Antipolis UTILISATION DES INHIBITEURS DE L'HYPUSINYLATION DE eIF5A POUR TRAITER LES PATHOLOGIES ISCHEMIQUES ET HYPOXIQUES

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166467B2 (en) * 2001-07-23 2007-01-23 Senesco Technologies, Inc. Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis
US7968523B2 (en) * 2001-07-23 2011-06-28 Senesco Technologies, Inc. Method for inducing apoptosis using apoptosis-specific EIF5-A
US7217517B2 (en) * 2001-07-23 2007-05-15 Senesco Technologies, Inc. Nucleic acids, polypeptides, and methods for modulating apoptosis
KR20050098954A (ko) * 2003-03-05 2005-10-12 세네스코 테크놀로지스 인코포레이티드 이아이에프-5에이1의 발현을 억제하기 위한 안티센스올리고뉴클레오타이드 또는 에스아이알엔에이의 이용
NZ544159A (en) * 2003-06-06 2009-04-30 Senesco Technologies Inc Inhibition of apoptosis-specific eIF-5A ("eIF-5A1") with antisense oligonucleotides and siRNAs as anti-inflammatory therapeutics

Also Published As

Publication number Publication date
EP1959010A2 (en) 2008-08-20
CA2588129A1 (en) 2006-06-08
NZ556236A (en) 2009-12-24
EP1959010A3 (en) 2009-02-25
AR051786A1 (es) 2007-02-07
EP1828383A2 (en) 2007-09-05
WO2006060823A2 (en) 2006-06-08
AU2005311586A1 (en) 2006-06-08
IL183585A0 (en) 2008-04-13
JP2008522591A (ja) 2008-07-03
KR20070077225A (ko) 2007-07-25
WO2006060823A3 (en) 2007-02-22

Similar Documents

Publication Publication Date Title
NO2019004I1 (no) patisiran: dekket gjennom sekvensene i kravene 1, 8 og 9 (se særlig krav 8 (b) og (c) i patentet. Det vises også til følgebrevet til søknaden.
ATE446105T1 (de) Trna-synthetase-fragmente
MX2010000537A (es) Anticuerpos monoclonales contra glipicano-3.
MX300732B (es) Celulasas, acidos nucleicos que las codifican y metodos para hacerlas y usarlas.
MY156315A (en) Anti-vegf antibodies
PL1794292T3 (pl) Warianty alfa-amylazy stabilizowane względem di- i/lub multimeryzacji, sposób ich wytwarzania oraz środki piorące i czyszczące zawierające te warianty alfa-amylazy
DK1836299T4 (da) Polypeptider, der har cellobiohydrolaseaktivitet, og polynukleotider, der koder for disse
TW200634154A (en) Apoptosis-specific EIF-5A and polynucleotides encoding same
ATE512980T1 (de) Polypeptide mit beta-glucosidase-aktivität sowie diese codierende polynukleotide
MX2010012849A (es) Reactivo de lisis, enlace y/o lavado para aislar y/o purificar acidos nucleicos.
WO2005116252A8 (en) Methods for evaluating ribonucleotide sequences
ATE527385T1 (de) Mit tumoren assoziierte genetische variationen
WO2010099477A3 (en) Polypeptide structural motifs associated with cell signaling activity
DK1844072T3 (da) MHC-oligomer og fremgangsmåde til fremstilling deraf
PL2291329T3 (pl) System oczyszczania cieczy, zwłaszcza oczyszczania wody balastowej
MX2008000230A (es) Proteinas de enlace il-6.
TN2011000524A1 (en) Antibodies specific to cadherin -17
TR201818614T4 (tr) Bir Kromatografi Kolonunun Rejenerasyonuna Yönelik Yöntem
WO2006135793A3 (en) Protein engineering with analogous contact environments
WO2009083950A3 (en) Biomarkers for the prediction of renal injury
EA201190210A1 (ru) Ингибиторы связывания киназы с белком
CL2008000666A1 (es) Compuestos derivados de triciclos sustituidos, inhibidores del transportador de metales divalentes-1; y uso para tratar una enfermedad asociada con un trastorno del hierro.
WO2007018671A3 (en) Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
DE602006010051D1 (de) Polypeptide mit endoglucanase-aktivtät und dafür codierende polynukleotide
GB201014028D0 (en) In-situ reagent